F. R. L. Crijns

Breakers of advanced glycation end products restore large artery properties in experimental diabetes

Bruce H. R. Wolffenbuttel, Chantal M. Boulanger, F. R. L. Crijns et al. · Proceedings of the National Academy of Sciences · 1998 · 433 citations · Full text

Aging, Glycobiology, Experimental Diabetes +19

Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats.

M. Huijberts, Bruce H. R. Wolffenbuttel, Harry A. Struijker Boudier et al. · Journal of Clinical Investigation · 1993 · 141 citations · Full text

Hypertension, Fluid Filtration, Biomedical Engineering +19

Proactive Approach for Safe Use of Antimicrobial Coatings in Healthcare Settings: Opinion of the COST Action Network AMiCI

Merja Ahonen, Anne Kahru, Angela Ivask et al. · International Journal of Environmental Research and Public Health · 2017 · 65 citations · Full text

Engineering, Healthcare Settings, Biomedical Engineering +20

Anti-microbial coating innovations to prevent infectious diseases (AMiCI): Cost action ca15114

Colum Dunne, Minna M. Keinänen‐Toivola, Anne Kahru et al. · Bioengineered · 2017 · 33 citations · Full text

Biofilms, Action Ca15114, European Hospitals +16

Aminoguanidine reduces regional albumin clearance but not urinary albumin excretion in streptozotocin-diabetic rats

M. Huijberts, Bruce H. R. Wolffenbuttel, F. R. L. Crijns et al. · Diabetologia · 1994 · 30 citations · Full text

Regional Albumin Clearance, Medicine, Diabetes +6